Acupuncture for substance use disorders: A systematic review and meta-analysis  by Grant, Sean et al.
RA
m
S
J
R
a
A
R
R
A
A
P
P
C
K
A
S
M
S
C
h
0
nDrug and Alcohol Dependence 163 (2016) 1–15
Contents lists available at ScienceDirect
Drug  and  Alcohol  Dependence
j ourna l h o me  pa ge: www.elsev ier .com/ locate /drugalcdep
eview
cupuncture  for  substance  use  disorders:  A  systematic  review  and
eta-analysis
ean  Grant ∗,  Ryan  Kandrack,  Aneesa  Motala,  Roberta  Shanman,  Marika  Booth,
eremy  Miles,  Melony  Sorbero,  Susanne  Hempel
AND, 1776 Main Street, P.O. Box 2138, Santa Monica, CA 90407-2138, USA
 r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 18 September 2015
eceived in revised form 18 January 2016
ccepted 20 February 2016
vailable online 3 March 2016
ROSPERO number for protocol:
ROSPERO number for protocol:
RD42015016040
eywords:
ccupuncture
ystematic review
eta-analysis
ubstance use disorder
a  b  s  t  r  a  c  t
Background:  This  systematic  review  aims  to estimate  the  effects  of  acupuncture  for  adults  with  substance
use  disorders  (SUDs).
Methods:  We  searched  7 electronic  databases  and  bibliographies  of previous  studies  to  identify  eligible
randomized  trials.  Two  independent  reviewers  screened  citations,  extracted  data,  and  assessed  risks  of
bias.  We  performed  random  effects  meta-analyses.  We  assessed  quality  of  evidence  using  the  GRADE
approach.
Results:  We included  41  studies  with  5,227  participants.  No  signiﬁcant  differences  were  observed  between
acupuncture  and  comparators  (passive  controls,  sham  acupuncture,  treatment  as  usual, and  active  inter-
ventions)  at post-intervention  for relapse  (SMD  −0.12; 95%CI  −0.46  to 0.22;  10  RCTs),  frequency  of
substance  use  (SMD  −0.27;  −2.67  to  2.13;  2 RCTs),  quantity  of  substance  use  (SMD  0.01;  −0.40  to  0.43;
3  RCTs),  and  treatment  dropout  (OR  0.82;  0.63  to  1.09;  22  RCTs).  We  identiﬁed  a signiﬁcant  difference  in
favor  of  acupuncture  versus  comparators  for withdrawal/craving  at post-intervention  (SMD  −0.57,  −0.93
to −0.20;  20  RCTs),  but  we identiﬁed  evidence  of  publication  bias.  We  also  identiﬁed  a signiﬁcant  dif-
ference  in  favor  of  acupuncture  versus  comparators  for anxiety  at post-intervention  (SMD  −0.74,  −1.15
to  −0.33; 6 RCTs).  Results  for withdrawal/craving  and  anxiety  symptoms  were  not signiﬁcant  at  longer
follow-up.  Safety  data  (12  RCTs)  suggests  little  risk  of  serious  adverse  events,  though  participants  may
experience  slight  bleeding  or  pain at needle  insertion  sites.
Conclusions:  Available  evidence  suggests  no  consistent  differences  between  acupuncture  and  compara-
tors  for  substance  use.  Results  in favor  of acupuncture  for withdrawal/craving  and  anxiety  symptoms  are
limited  by  low  quality  bodies  of evidence.
© 2016  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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. Introduction
Substance use disorders (SUDs) are common, highly disabling,
nd associated with signiﬁcant consequences. In the U.S., twelve-
onth prevalence rates for alcohol use disorder (AUD) and other
UDs are 13.9% and 3.9%, respectively, while lifetime prevalence
ates for AUD and other SUDs are 29.1% and 9.9%, respectively
Grant et al., 2015, 2016). Worldwide, at least 150 million peo-
le have used an illicit drug such as cannabis, opioids, or cocaine
Degenhardt and Hall, 2012), while individuals aged 15 years or
lder drink 6.2 liters of pure alcohol on average per year (World
ealth Organization, 2014). SUDs are associated with various phys-
cal health problems—infectious diseases, cardiovascular disease,
iver and pancreatic disease, neurologic impairment, diabetes, can-
er, and physical injury (Cargiulo, 2007; Degenhardt and Hall, 2012;
ehm, 2011). Persons with SUDs also often have comorbid psychi-
tric disorders such as major depressive disorder, bipolar I disorder,
peciﬁc phobias, antisocial personality disorder, and borderline
ersonality disorder (Grant et al., 2015, 2016). In addition to health
roblems, SUDs are associated with signiﬁcant social and economic
onsequences, such as interpersonal and relationship issues, lost
roductivity, homelessness, poverty, violent and property crime,
nd incarceration (National Drug Intelligence Center, 2011; NIDA,
008; Rehm et al., 2009; World Health Organization, 2014). Given
heir prevalence and societal impact, addressing SUDs is currently
 policy priority.
Improving access to high quality healthcare is a key facet of SUD
olicy reform. The Patient Protection and Affordable Care Act, and
he Mental Health Parity and Addiction Equity Act, have provided
everal million more people in the U.S. with coverage for SUDs ser-
ices. This substantial increase in access to care has consequently
ed to greater emphasis on identifying effective interventions for
UDs in the healthcare system (IOM, 2015). Despite the sizeable
vidence base for interventions, SUDs often go untreated: only 7.7%
nd 13.5% of those with 12-month AUD and other SUDs sought
reatment or help for these disorders, possibly reﬂecting contin-
ed skepticism in the effectiveness of SUD treatments (Grant et al., . . .  . .  . . . . .  . . . .  . . . .  . . .  . . .  . . .  .  .  . . .  . . . .  .  . . . . . . .  . . . . .  .  . . .  . . . . . .  .  . .  .  .  .  .  . . . .  . . .  . . . 14
2015, 2016). These data highlight the need to systematically syn-
thesize high-quality evaluation data on prominent or popular SUD
interventions to underpin their coverage and scale-up in health
systems (IOM, 2015).
1.1. Needle acupuncture for SUDs
Integrative medicine, which combines conventional Western
medicine with complementary and alternative medicine (CAM)
approaches, has been gaining traction as a healthcare service
modality in the U.S. (IOM, 2009). Acupuncture for treating SUDs
is one CAM intervention that has increased in popularity in recent
decades (Lu et al., 2009). According to Traditional Chinese Medicine
(TCM), balancing the ﬂow of energy in the body (known as “Qi”),
which ﬂows through meridian points and connects bodily organs
and systems, can help to improve health. Acupuncture protocols
generally involve inserting and manipulating thin solid needles into
speciﬁc documented meridian points in order to relieve blockages
in the ﬂow of Qi and thereby create a positive therapeutic impact
on bodily organs, systems, and functions (Lin et al., 2012).
As a treatment for SUDs, acupuncture primarily involves insert-
ing and stimulating needles at meridian points primarily thought
to be associated with regulating dopamine and decreasing corti-
sol, thereby aiming to bring balance to dopamine levels affected
by substance use and ultimately producing a decrease in craving
and withdrawal symptoms (Lua and Talib, 2012). Recent research
has been conducted on animals to assess the neurochemical and
biological basis of acupuncture, with the purported primary mech-
anism for SUD treatment as the modulation of dopamine neurons
along the mesolimbic pathway, which leads to negatively reinforc-
ing the effects of drugs (Yang et al., 2008). Acupuncture appears to
have ﬁrst emerged as a treatment for SUDs in 1972 when a doc-
tor in Hong Kong reported that acupuncture relieved symptoms
of opioid withdrawal (Cui et al., 2008). It began to be adopted in
Western clinical settings in the 1980s via the US  National Acupunc-
ture Detoxiﬁcation Association (NADA) protocol, which involves
bilateral acupuncture of one to ﬁve speciﬁc ear points (i.e., kidney,
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iver, lung, shen men, and sympathetic) for 35 to 45 minute sessions
n a group setting in order to relieve withdrawal symptoms, pre-
ent symptoms of craving, and increase patient participation rates
n long-term SUD treatment programs (Gates et al., 2006; Mills
t al., 2005). The prerequisite knowledge and skills for performing
cupuncture, as well as its use with those diagnosed with SUDs,
ender acupuncture more appropriate for delivery in specialty care
ather than in primary care settings (Brumbaugh, 1993).
.2. Efﬁcacy and safety of needle acupuncture for SUDs
Given the growing use and acceptance of CAM by the American
ublic (IOM, 2005), determination of its efﬁcacy and safety is cru-
ial prior to its widespread use by healthcare professionals to treat
UDs. Most clinical practice guidelines for SUDs do not include any
ecommendations for or against acupuncture (CAMH, 2011; NICE,
011; VA/DoD, 2009; WHO, 2014); one guideline explicitly does
ot recommend its use, though it cites only one randomized con-
rolled trial (RCT) rather than a systematic review of the evidence
APA, 2006). Moreover, an expert panel of addiction experts and
ractitioners rated acupuncture as a potentially discredited treat-
ent that may  be ineffective or even detrimental (Norcross et al.,
010). Nevertheless, 3.5% of private non-proﬁt facilities and 11.1%
f federal government facilities offer acupuncture services for the
reatment of SUDs (SAMHSA, 2014).
The lack of discussion of acupuncture in guidelines and appar-
ntly discredited view among practitioners is striking given its
revalence of use, highlighting the need for a comprehensive sys-
ematic review in this area that tackles several challenges involved
ith synthesizing research on acupuncture. For instance, certain
eographical regions—namely East Asia—publish unusually high
roportions of RCTs that have results in favor of acupuncture, with
ublication bias (involving the selective reporting of outcomes or
rials with results favoring acupuncture) as a possible explanation
or this pattern (Vickers et al., 1998). Moreover, there is consid-
rable debate as to whether “sham” acupuncture via non-speciﬁc
oints (i.e., placebo acupuncture at acupoints thought in TCM to be
nrelated to SUDs) and superﬁcial needling (minimal or no inser-
ion of needles in the skin at acupoints thought to be related to
UDs) may  actually have positive effects and thus serve as inap-
ropriate “placebo” comparators (Lua and Talib, 2012; Mills et al.,
005). Previous systematic reviews in this area have investigated
cupuncture for alcohol, opiates, and cocaine speciﬁcally (Cho and
hang, 2009; Gates et al., 2006; Jordan, 2006; Kim et al., 2006;
in et al., 2012; Liu et al., 2009; Lua and Talib, 2012; Mills et al.,
005), with reviews generally concluding that more high-quality
rials are needed to determine the efﬁcacy of acupuncture for spe-
iﬁc SUDs. However, no systematic review has synthesized all RCTs
f acupuncture for SUDs generally, with over 40 randomized con-
rolled trials (RCTs) conducted to date. Our review updates these
revious reviews, considers the efﬁcacy of acupuncture for SUDs
enerally, and assesses various outcomes associated with SUDs.
. Materials and methods
This review was registered on PROSPERO (CRD42015016040)
rior to completing formal screening of search results against eli-
ibility criteria. Akin to the rationale of registering RCTs prior
o participant recruitment (Dickersin and Renne, 2003), registra-
ion of systematic reviews prior to completing formal screening of
earch results is essential to minimize reporting biases (e.g., selec-
ive reporting of positive outcomes), providing transparency in the
eview process (e.g., tracking major changes in planned methods),
nd informing interested stakeholders of ongoing and completed
eviews (Booth et al., 2012). We  used two guidelines to develop thisependence 163 (2016) 1–15 3
manuscript in order to improve its accuracy, comprehensiveness,
and transparency: the Preferred Reporting Items for Systematic
Reviews and Meta-analyses Statement (Moher et al., 2009), an
evidence- and consensus-based minimum set of items for report-
ing intervention reviews; and the Methodological Expectations of
Campbell Collaboration Intervention Reviews guidance (Campbell
Collaboration, 2014), a set of explicit and transparent expectations
for reporting intervention reviews set by the Campbell Collabora-
tion.
2.1. Objective
This systematic review aims to estimate the efﬁcacy and safety
of acupuncture for SUDs generally and by the type of substance
targeted.
2.2. Search strategy
We searched several databases (PubMed, PsycINFO, AMED,
MANTIS, CINAHL, CENTRAL, and EMBASE) from their inception
through November 2014 (see Online Supplement 1). Search strings
were developed by the Chief Reference Librarian for RAND’s Knowl-
edge Services (RS) and informed by search strings of previous
reviews in this area (Cho and Whang, 2009; Gates et al., 2006;
Jordan, 2006; Kim et al., 2006; Lin et al., 2012; Liu et al., 2009;
Lua and Talib, 2012; Mills et al., 2005). The databases not unique to
acupuncture (particularly PubMed) have preferable indexing and
search features in addition to adequate coverage of the acupunc-
ture literature, whereas databases speciﬁc to CAM (i.e., AMED and
MANTIS) are useful specialty databases for speciﬁcally identifying
acupuncture RCTs (Cogo et al., 2011). We  restricted our search to
English-language publications indexed in international databases
due to resource constraints and the abovementioned concerns
raised in the scientiﬁc literature (Vickers et al., 1998); several
reviews have found that excluding trials published in languages
other than English generally has little impact on summary effect
estimates (Jüni et al., 2002; Moher et al., 2000).
2.3. Eligibility criteria
We only included parallel group, individually- or cluster-
randomized controlled trials. Studies reported only in conference
proceedings or abstracts were excluded. Studies were limited to
adults (male and female) who  are 18 years of age or older. Partici-
pants must have been diagnosed with alcohol, opioid, stimulant,
and/or cannabis use disorder using DSM-IV, DSM-5  or ICD cri-
teria. Studies that administered thin or ﬁne solid needles into
known acupuncture points, either as an adjunctive or mono-
therapy, were included. Studies involving full-body acupuncture,
auricular acupuncture, or other speciﬁc body sites, with or without
electro-stimulation, were included. Studies involving acupuncture
via laser, heat, or light were excluded unless needles were also
used. Studies involving dry-needling or trigger-point and not refer-
ring to traditional acupuncture were also excluded. Studies that
included sham acupuncture, “treatment as usual” or “standard
care,p¨assive comparators (e.g., wait-list control, no-treatment), or
other active treatments were included. Studies that reported one or
more of the following outcomes were included: relapse, frequency
or quantity of substance use, withdrawal/craving symptoms, treat-
ment dropout, anxiety symptoms, health-related quality of life, and
adverse events. Studies could have involved any treatment dura-
tion and follow-up period. Studies were not limited by treatment
setting.
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.4. Inclusion screening
Two independent reviewers (SG and RK) screened titles and
bstracts of retrieved citations, as well as full-text publications of
itations judged as potentially eligible by one or both reviewers
t the title and abstract screening stage. Any disagreements at the
ull-text stage were resolved through discussion within the review
uthor team.
.5. Data extraction
The two reviewers each independently extracted study-level
ata in an electronic database (DistillerSR) using a data collec-
ion form designed by the project team (see Online Supplement 2).
he reviewers pilot-tested the form on a few well-reported stud-
es to ensure agreement of interpretation, and they independently
ssessed risks of bias of included studies using the Cochrane Risk of
ias tool (Higgins et al., 2011)—Cochrane’s recommended approach
or assessing risks of bias in RCTs included in systematic reviews of
nterventions. Speciﬁcally, the reviewers assessed the six domains
peciﬁed in the Cochrane Risk of Bias tool: random sequence gen-
ration (selection bias), allocation concealment (selection bias),
linding of participants and providers (performance bias), blinding
f outcome assessors (detection bias), completeness of report-
ng outcome data (attrition bias), and selective outcome reporting
reporting bias). The project lead extracted all outcome data, and
wo statisticians (MB, JM)  analyzed the data.f Search Results.
2.6. Data synthesis
When sufﬁcient data were available, we  performed random
effects meta-analyses using the Hartung-Knapp-Sidik-Jonkman
method (Hartung, 1999; Hartung and Knapp, 2001; Sidik and
Jonkman, 2006); this method may  be preferred when the number
of studies pooled is small and when there is evidence of hetero-
geneity (IntHout et al., 2014), and error rates are more robust than
the previously used DerSimonian and Laird method (Sánchez-Meca
and Marín-Martínez, 2008). Outcomes were grouped by length
of follow-up, and the I2 statistic was used to assess the degree
of heterogeneity per each analysis (Higgins et al., 2003). When
sufﬁcient data were available, we also conducted subgroup anal-
yses to examine whether there were differences in effect sizes by
type of substance used, acupuncture, co-intervention status, and
comparison group. In order to prevent overlap of data between sub-
groups, studies that could be classiﬁed into multiple sub-groups
(e.g., a three-arm trial with two  different comparison groups) were
assigned to the sub-group with the fewest studies. We also inves-
tigated publication bias for all main analyses with sufﬁcient data
using Begg’s rank correlation test for funnel plot asymmetry (Begg
and Mazumdar, 1994) and Egger’s test for funnel plot asymmetry
(Egger et al., 1997). Common indices for interpreting clinical effect
sizs were used: SMD  = 0.2 or OR = 0.60 for a small clinical effect,
SMD  = 0.5 or OR = 0.29 for a medium clinical effect, and SMD  = 0.8
or OR = 0.15 for a large clinical effect (Chen et al., 2010). For some
outcomes, we  combined dichotomous and continuous data to max-
imize the number of studies available per analysis.
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.7. Quality of the body of evidence
We  assessed the quality of the body of evidence for each out-
ome using the GRADE approach (Balshem et al., 2011), in which the
uality of a body of evidence underpinning an effect estimate repre-
ents conﬁdence that the estimate is close to the quantity of speciﬁc
nterest (e.g., the effect of an intervention in the population of inter-
st). Over 90 organizations and societies internationally—including
he Agency for Healthcare Research and Quality, American College
f Physicians, BMJ, Cochrane, National Institute for Health and Care
xcellence, and World Health Organization—have endorsed or are
sing GRADE for systematic reviews and clinical practice guide-
ines (GRADE Working Group, 2015). We  speciﬁcally assessed the
ollowing four aspects of the body of evidence underpinning each
ffect estimate, as recommend by the GRADE approach: study lim-
tations via our risk of bias assessments; directness via how well
tudies addressed our speciﬁed population of interest; consistency
ia the magnitude of heterogeneity; and precision via the width of
onﬁdence intervals. The quality of the body of evidence was  graded
n a 4-item scale (very low, low, moderate, and high) to reﬂect our
onﬁdence that effect estimates lie close to the true effect for a
iven outcome and are stable (i.e., further research is very unlikely
o have an important impact on the effect estimate).
. Results
.1. Search results
We  examined 1,014 titles and abstracts (Fig. 1); of 168 full-texts
dentiﬁed as potentially eligible, 120 articles were excluded (Online
upplement 3). We  identiﬁed 41 eligible studies reported across 48
rticles (Table 1); all studies provided efﬁcacy data, and 12 RCTs
rovided adverse event data.
.2. Included studies
.2.1. Design. All RCTs randomized participants individually (Sup-
lementary Material 4). Studies assigned 5,227 participants,
anging in size from 17 (Leung, 1977) to 620 participants (Margolin
t al., 2002b), with a median sample size of 72 participants per
tudy. Twenty-nine studies did not report any information about a
ower calculation, 10 studies reported an a priori power calcula-
ion with targeted sample size achieved, and two  studies noted a
ost hoc analysis indicating insufﬁcient power (Avants et al., 1995;
anssen et al., 2012). Twenty-eight studies were two-arm RCTs, 11
tudies were three-arm RCTs, and two studies were four-arm RCTs..2.2. Setting. Studies were conducted in 12 countries: 21 in the
S; ﬁve in China; three in Canada; two each in Germany, Iran, and
he UK; and one each in Bulgaria, Malaysia, South Korea, Sweden,ependence 163 (2016) 1–15 5
Switzerland, and Taiwan. All studies occurred in SUD specialty care
settings, with 20 studies taking place in outpatient settings, and 21
studies in inpatient settings. Most studies took place at one site,
though one study took place at two sites (Wells et al., 1995), three
studies took place at three sites (Black et al., 2011; Lua and Talib,
2013; Man  and Chuang, 1980), and one study took place at six sites
(Margolin et al., 2002b).
3.2.3. Participants. Average age ranged from 28 to 45 years. One
RCT had only females (Janssen et al., 2012), and 10 RCTs had only
males (Bullock et al., 1987; Chang et al., 2010; Liang et al., 2012;
Lua and Talib, 2013; Man  and Chuang, 1980; Montazeri et al., 2002;
Otto et al., 1998; Song et al., 2010, 2012); of the remaining RCTs,
the proportion of males ranged from 50–94%.
3.2.4. Interventions. Acupuncture sessions ranged from 15 to
45 min  per session, from one to 21 sessions, and for one to 32
weeks in total duration. Thirty-two RCTs provided data on auricular
acupuncture, of which 12 RCTs speciﬁcally referred to follow-
ing the NADA protocol (Avants et al., 2000; Bearn et al., 2009;
Black et al., 2011; Chang et al., 2010; Janssen et al., 2012; Killeen
et al., 2002; Konefal et al., 1994, 1995; Kunz et al., 2007; Lua
and Talib, 2013; Margolin et al., 2005, 2002b). Nine RCTs evalu-
ated TCM acupuncture, varying in session length, frequency, and
targeted acupoints. Two TCM acupuncture RCTs applied moxibus-
tion (Song et al., 2010, 2012) to enhance acupuncture. Seven RCTs
also involved electro-acupuncture (i.e., electro-stimulation of nee-
dles), of which four were auricular acupuncture RCTs that provided
electro-acupuncture on somatic acupoints, and one that involved
electro-stimulation of auricular sites.
3.2.5. Comparators. Seven RCTs provided data on acupuncture (as
an adjunctive therapy to treatment as usual, ‘TAU’) versus TAU
alone. There were 19 sham acupuncture comparators across all
RCTs: 15 involved non-speciﬁc points not intended to address
chemical dependency, and four involved superﬁcial needling at
points intended for chemical dependency. We identiﬁed seven
passive intervention comparators: three involved no treatment,
three involved relaxing in a soothing room, and one involved
a sham-laser passive comparator. We  identiﬁed 16 active com-
parators from 15 RCTs: nine involved pharmacotherapy therapy,
two involved relaxation therapy, one involved aromatherapy, one
involved transdermal stimulation, one involved frequent urine
testing (to promote abstention from substance use), one involved
brainwave modiﬁcation, and one involved laser acupuncture. In
addition, four trials compared different doses of acupuncture (e.g.,
using 1–3 points from NADA protocol; providing eight, 16, or 28
acupuncture sessions).
3.2.6. Outcomes. Length of follow-up ranged from immediately
post-intervention to 12-months post-intervention. Eleven RCTs
provided information on relapse to substance use, 22 on treatment
dropout, nine on withdrawal/craving symptoms, two on frequency
of use, three on quantity of use, three on health-related quality of
life, seven on functional status, and 12 on adverse events.
3.3. Risks of bias
Risk of bias assessments for each included study can be found in
Supplementary material 5, with supporting data in Supplementary
material 6. Most studies were rated with unclear risk of selection
bias due to lack of reporting random sequence generation and allo-
cation concealment methods. All studies were de facto rated high
risk of performance bias for providers, as it is generally impossi-
ble for a provider to be blinded from delivery of acupuncture. One
6 S. Grant et al. / Drug and Alcohol Dependence 163 (2016) 1–15
Table 1
Evidence Table of included studies.
Study details Participants Intervention
Avants et al. (1995)
Country: United States
Number of participants: 40 (20 acupuncture, 20 sham)’
Age (years): 35.2 (SD 7.4). Gender: 55% male
Baseline substance use: Average of 1.7 g of cocaine for 2.3 days per
week
Content: Auricular (lung, Shen Men, sympathetic) sites plus one in
each hand (LI-4)
Dosage: 45 min, 5 × a week/6 weeks
Avants et al. (1995)
Country: United States
Number of participants: 82 (28 acupuncture, 27 sham, 27 passive)
Age (years): 37 (SD 6). Gender: 57% male
Baseline substance use: “unremitting cocaine use”
Content: Auricular (liver, lung, Shen Men, and sympathetic)
Dosage: 45 min, 5 × a week/8 weeks
Bearn et al. (2009)
Country: United Kingdom
Number of participants: 82 (48 acupuncture, 34 sham)’
Age (years): acupuncture = 36.2 (SD 7.0). Gender:
acupuncture = 73% male
Baseline substance use: Heroin = 73% acupuncture, Codeine = 19%
Content: Auricular (liver, lung, Shen Men, and sympathetic)
Dosage: 30–45 min, 5 × a week/2 weeks
Black et al. (2011)
Country: Canada
Number of participants: 140 (45 acupuncture, 54 sham, 41 passive)
Age (years): 41.2 (SD 12). ’Gender: 51% male
Baseline substance use: Nicotine (31.7%), alcohol (28.7%), cocaine
(16.8%)
Content: Auricular (kidney, liver, lung, Shen Men, and
sympathetic)
Dosage: 45 min, 1–2 × a week/2 weeks
Bullock et al. (1987)
Country: United States
Number of participants: 54 (27 acupuncture, 27 sham)”
Age (years): 42.’Gender: 100% male
Baseline substance use: 98.1% alcohol as single drug of misuse
Content: Auricular (lung, Shen Men, and liver/kidney/occiput) and
wrist (L.I. 4, S.J. 5)
Dosage: 45 min, 2–5 × a week/11 weeks
Bullock et al. (1989)
Country: United States
Number of participants: 80 (40 acupuncture, 40 sham)”
Age (years): 42.’Gender: 94% male
Baseline substance use: 100% alcohol as single drug of misuse
Content: Auricular (lung, Shen Men, sympathetic) and hand (LI
4Hoku)
Dosage: 30 min, 2–5 × a week/8 weeks
Bullock et al. (1999)
Country: United States
Number of participants: 236 (numbers for each group not
reported)
Age (years): 30.2 (SD 6.0). ’Gender: 70% male
Baseline substance use: “Cocaine abuse” by all participants
Content: Auricular (three unspeciﬁed points)
Dosage: 45 min, 3–5 × a week/8 weeks
Bullock et al. (1999)
Country: United States
Number of participants: 202 (numbers for each group not
reported)
Age (years): 30.2.’Gender: 70% male
Baseline substance use: Not reported
Content: Auricular (ﬁve unspeciﬁed points) and one wrist point
Dosage: 45 min, 3–4 × a week/8 weeks
Bullock et al. (2002)
Country: United States
Number of participants: 503 (132 acupuncture, 133 sham, 134
TAU, 104 symptom-based acupuncture)
Age (years): 38 (SD 10). Gender: 50% male. Substance use: Not
reported
Content: Auricular (liver, lung, Shen Men, and sympathetic)
Dosage: 40 min, 6 × a week/3 weeks
Chan et al. (2014)
Country: Taiwan
Number of participants: 60 (30 acupuncture, 30 sham)
Age (years): 36.2. Gender: 82% male
Baseline substance use: Heroin abuse history on average of 7.05
years
Content: Auricular (Shen Men) and body electroacupuncture
(Hegu, Zusanli)
Dosage: 20 min, 2 × a week/4 weeks
Chang et al. (2010)
Country: United States
Number of participants: 67 (23 acupuncture, 23 active, 21 TAU)”
Age  (years): acupuncture = 46.6 (SD 8.3). Gender: 100% male
Baseline substance use: 72% alcohol as substance of choice
Content: Auricular (kidney, liver, lung, Shen Men, sympathetic)
Dosage: 45 min, 2 × a week/10 weeks
Janssen et al. (2012)
Country: Canada
Number of participants: 89 (50 acupuncture, 39 active)”
Age (years): acupuncture = 28.2 (SD 5.6). Gender: 0% male
Baseline substance use: No empirical data reported
Content: Auricular (kidney, liver, lung, Shen Men, sympathetic)
Dosage: 45 min, 7 × a week/? weeks
Karst et al. (2002)
Country: Germany
Number of participants: 34 (17 acupuncture, 17 sham)”
Age (years): 43.3 (SD 9.0). ’Gender: 88% male
Baseline substance use: acupuncture = 279 g/day of alcohol
Content: Auricular (kidney, liver, lung, Shen Men, sympathetic)
and GV 20, Extra 1, LI 4
Dosage: 30 min, 5 × a week/2 weeks
Killeen et al. (2002)
Country: United States
Number of participants: 30 (15 acupuncture, 15 sham)”
Age (years): acupuncture = 37 (SD 4.7). Gender: 60% male
Baseline substance use: acupuncture = 18.3 days of cocaine use
(past month)
Content: Auricular (kidney, liver, lung, Shen Men, sympathetic)
Dosage: 45 min, 1 × a week/1 week
Konefal et al. (1994)
Country: United States
Number of participants: 568 (186 acupuncture, 194 active, 188
TAU)”
Age (years): acupuncture = 37 (SD 4.7). Gender: 60% male
Baseline substance use: Documented substance use disorder
(various)
Content: Auricular (kidney, liver, lung, Shen Men, and
sympathetic)
Dosage: 45 min, 2–5 × a week/16 weeks
Konefal et al. (1995)
Country: United States
Number of participants: 321 (113 5-needle, 110 5-needle + body,
98  1-needle)”
Age (years): < 24: 15%; 25–34: 50%; 35+: 35%. Gender: 69% male
Baseline substance use: Crack: 34.6%, Alcohol 22.7%, Cocaine: 20.2%
Content: Five-needle auricular acupuncture according to the NADA
protocol
Dosage: 45 min, 2–5 x a week/16 weeks
Kunz et al. (2007)
Country: Germany
Number of participants: 109 (55 acupuncture, 54 aromatherapy)”
Age (years): acupuncture = 47.9 (SD 9.8). Gender: 82% male
Baseline substance use: acupuncture = 15.6 years of dependence on
alcohol
Content: Five-needle auricular acupuncture according to the NADA
protocol
Dosage: 45 min, 5 × a week/1 week
Lee et al. (2014)
Country: South Korea
Number of participants: 20 (10 acupuncture, 10 sham)”
Age (years): acupuncture = 43 (SD 6.8). Gender: 100% male
Baseline substance use: acupuncture = 16.3 drinking days per
month
Content: TCM acupuncture at Zhubin (KI9)
Dosage: 15 min, 2 × a week/4 weeks
Leung (1977)
Country: Canada
Number of participants: 17 (8 acupuncture, 9 sham)”
Age (years): 39.8. Gender: 63% male
Baseline substance use: “Addicted to” narcotics (9), alcohol (5),
other drugs (3)
Content: Lung point of the ear and Spleen 6 as the auxiliary
somatic point
Dosage: 20 min, 11 × a week/1 week
Liang et al. (2012)
Country: China
Number of participants: 62 (21 acupuncture, 21 active, 20 passive)”
Age (years): 39 (SD 8). Gender: 100% male
Baseline substance use: Dependent on opioids
Content: Bilateral acupoints at Neiguan (PC 6)
Dosage: 20 min, 3 × a week/4 weeks
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Table  1 (Continued)
Study details Participants Intervention
Lipton et al. (1994)
Country: United States
Number of participants: 150 (73 acupuncture, 77 sham)”
Age (years): acupuncture = 30.3. Gender: 72% male
Baseline substance use: acupuncture = smoked cocaine 19.6 days
(past month)
Content: Acupuncture bilaterally at four ear points (liver, lung,
Shen Men, and sympathetic)
Dosage: 45 min, 1–7 × a week/4.5 weeks
Lua and Talib (2013)
Country: Malaysia
Number of participants: 97 (55 acupuncture, 42 active)
Age (years): 37.7. Gender: 100% male
Baseline substance use: 54.6% of participants used opioids
Content: Auricular acupuncture bilaterally (kidney, liver, lung,
Shen Men, sympathetic)
Dosage: 30 minutes, 3x a week/8 weeks
Man  and Chuang (1980)
Country: United States
Number of participants: 35 (numbers for each group not reported)
Age (years): 32.4. Gender: 100% male
Baseline substance use: Drug abuse history of 5–20 years (mean of
10 years)
Content: Auricular acupuncture bilaterally (lung, stomach)
Dosage: 30 min, 7 × a week/4 weeks
Margolin et al. (2002a,b)
Country: United States
Number of participants: 620 (222 acupuncture, 203 sham, 195
passive)”
Age (years): 38.8 (SD 7.60). Gender: 69% male
Baseline substance use: Cocaine use for average of 10.94 years
Content: Auricular acupuncture bilaterally (liver, lung, Shen Men,
sympathetic)
Dosage: 40 min, 5 × a week/8 weeks
Margolin et al. (2005)
Country: United States
Number of participants: 40 (20 acupuncture, 20 active)’
Age (years): 42.83 (SD 7.4). Gender: 60% male
Baseline substance use: Opiate use for 21.32 years, cocaine for
18.07 years
Content: NADA protocol auricular acupuncture (kidney, liver, lung,
Shen Men, sympathetic)
Dosage:? minutes, 5 × a week/8 weeks
Montazeri et al. (2002)
Country: Iran
Number of participants: 40 (20 acupuncture, 20 active)’
Age (years): acupuncture = 32 (SD 8). Gender: 100% male
Baseline substance use: acupuncture = 50% abused opium, 50%
abused heroin
Content: LI4, PC6, ST36, HT7, LR3, DU14, and DU20 acupoints
Dosage: 45 min, 3 × a week/1 week
Mu et al. (2013)
Country: China
Number of participants: 60 (30 acupuncture, 30 active)’
Age (years): 32.5 (SD 6.35). ’Gender: 58% male
Baseline substance use: “Heroin addiction”
Content: Bilaterally at Jiaji (EX-B 2) points (level of T5-7) &
Shenshu (BL23)
Dosage: 20 min, 5–7 × a week/2 weeks
Otto et al. (1998)
Country: United States
Number of participants: 36 (25 acupuncture, 11 sham)”
Age (years): 38.9. Gender: 100% male
Baseline substance use: DSM-III-R criteria for cocaine dependence
Content: Auricular acupuncture bilaterally (kidney, liver, lung,
Shen Men, sympathetic)
Dosage: 30–45 min, 1–5 × a week/12 weeks
Pirmoradi and Abdollahi (2008)
Country: Iran
Number of participants: 96 (48 acupuncture, 48 active)”
Age (years): Not reported. Gender: 92% male
Baseline substance use: “Heroin/opium addiction”
Content: Auricular (kidney, liver, lung, Shen Men, sympathetic),
LI4, HT7, PC6, ST36, LR3
Dosage: 30–45 min, 1–21 × week/32 weeks
Rampes et al. (1997)
Country: United Kingdom
Number of participants: 59 (23 acupuncture, 20 sham, 16 TAU)”
Age (years): acupuncture = 38.3 (SD 10.8). Gender:
acupuncture = 83% male
Baseline substance use: “Dependence on or abuse of alcohol”
Content: Auricular acupuncture bilaterally (lung, Shen Men,
sympathetic)
Dosage: 30 min, 1 × a week/6 weeks
Richard et al. (1995)
Country: United States
Number of participants: 186 (41 acupuncture, 40 active, 57 active,
48 TAU)”
Age (years): 26–30: 28.5%; 31–35: 25%. Gender: 62% male
Baseline substance use: “Crack cocaine addiction”
Content: Auricular acupuncture at ﬁve ear points for drug
detoxiﬁcation
Dosage: 30 min, 3–7 × a week/4.5 weeks
Sapir-Weise et al. (1999)
Country: Sweden
Number of participants: 72 (36 acupuncture, 36 sham)”
Age (years): 45 (SD 9). ’Gender: 71% male
Baseline substance use: Alcohol-dependent according to DSM-III-R
Content: Auricular acupuncture bilaterally (lung, Shen Men,
sympathetic)
Dosage: 45 min, 2–5 × a week/10 weeks
Song et al. (2010)
Country: China
Number of participants: 90 (45 acupuncture, 45 passive)”
Age (years): acupuncture = 33.38 (SD 6.39). Gender: 100% male
Baseline substance use: More than 5 months of heroin withdrawal
Content: Acupuncture at Baihui (GV20), Neiguan (PC6).
Moxibustion to Zusanli (ST36)
Dosage: 30 min, 2 × a week/8 weeks
Song et al. (2012)
Country: China
Number of participants: 62 (35 acupuncture, 27 passive)”
Age (years): acupuncture = 35.0 (SD 7.18). Gender: 100% male
Baseline substance use: DSM-III diagnosis of opioid dependence
Content: Acupuncture at Baihui (GV20), Neiguan (PC6), and Shen
Men  (HT7). Moxibustion Zusanli (ST36).
Dosage: 30 min, 2 × a week/8 weeks
Toteva and Milanov (1996)
Country: Bulgaria
Number of participants: 118 (50 acupuncture, 68 active)”
Age (years): acupuncture = 32.3. Gender: 76% male
Baseline substance use: acupuncture = 8.3 years alcohol
dependence
Content: Acupuncture at LI-4 (Hegu), LI-11 (Quchi), PC-6
(Neiguan), SJ-5 (Waiguan), SI-4 (Wangu), GB-8 (Shuaigu), GB-14
(Yangbai), HT-7 (Shen Men), Taiyang (extra), and Yintang (extra).
Dosage: 20–30 min, 7 × a week/2 weeks
Trumpler et al. (2003)
Country: Switzerland
Number of participants: 48 (15 acupuncture, 17 laser, 16 sham
laser)”
Age (years): acupuncture = 45. Gender: 58% male
Baseline substance use: “actively drinking” at the time they were
admitted
Content: Auricular acupuncture on 2–10 (out of 24) prespeciﬁed
points for dependency, chosen individually at each session
Dosage: 30–40 min, 7 × a week/1 week
Washburn et al. (1993)
Country: United States
Number of participants: 100 (55 acupuncture, 45 sham)”
Age (years): acupuncture = 40.5. Gender: acupuncture = 64% male
Baseline substance use: History of intravenous use of heroin
Content: Auricular acupuncture (kidney, lung, Shen Men, and
sympathetic)
Dosage: 20–45 min, 7 × a week/3 weeks
Wells et al. (1995)
Country: United States
Number of participants: 60 (31 acupuncture, 29 sham)’
Age (years): 18–25: 4; 26–35: 14; 36–45: 32; 46+: 10. Gender: 52%
male
Baseline substance use: Opiate dependence
Content: Auricular acupuncture (kidney, liver, lung, Shen Men,
sympathetic)
Dosage: 40 min, 5–7 × a week/26 weeks
White Michael et al. (2006)
Country: United States
Number of participants: 336 (166 acupuncture, 170 active)
Age (years): Not reported. Gender: acupuncture = 79% male
Baseline substance use: acupuncture = 48% positive drug test at
entry
Content: Auricular acupuncture
Dosage: 35–45 min, 5 × a week/4.5 weeks
Worner et al. (1992)
Country: United States
Number of participants: 56 (19 acupuncture, 21 transdermal, 16
TAU)”
Age  (years): acupuncture = 41.9 (SD 2.3). Gender: 88% male
Baseline substance use: acupuncture = 267.6 g alcohol daily
Content: Bilateral body points (liver 3, stomach 36, triple heater 5,
large intestine 4; midline point; govenor vessel 20). Bilateral ear
points (Shen Men  and lung)
Dosage: 30 min, 3 × a week/13 weeks
Zeng et al. (2005)
Country: China
Number of participants: 70 (35 acupuncture, 35 active)”
Age (years): acupuncture = 33.2 (SD 5.51). Gender:
acupuncture = 84% male
Baseline substance use: All current heroin users
Content: Acupuncture at Baihui (GV 20), Dazhui (GV 14), Shendao
(GV 11), Lingtai (GV 10), Zhiyang (GV 9) and Mingmen (GV 4) of
the Du Channel
Dosage: 30 min, 7 × a week/1.5 weeks
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tudy (Lipton et al., 1994) aimed to mitigate this bias by using addi-
ional staff to ensure that the acupuncturist and participants did
ot communicate at all during treatment, whereas another study
ad a treatment protocol in place to limit interaction between the
cupuncturist and participant beyond necessity (Margolin et al.,
002a, 1998). Almost half of the studies were rated as high risk
f performance bias related to blinding of intervention partici-
ants. Four studies had multiple treatment arms, in which one
rm received sham acupuncture and the other arm did not involve
cupuncture: as such, these studies were low risk of performance
ias for true versus sham acupuncture comparisons, and high risk
f performance bias for acupuncture versus non-acupuncture com-
arisons. A majority of studies were rated as a low risk of detection
ias due to blinding outcome assessors. Twenty studies were rated
s low risk of attrition biases related to missing data in the RCT, two
ith unclear risk of bias, and 19 as high risk of bias. Most studies
ere rated with unclear risk of reporting bias related to subjective
utcome reporting.
.4. Efﬁcacy of acupuncture for SUDs
.4.1. Substance use relapse. Ten RCTs (24% of RCTs) with 1,175 par-
icipants (22% of randomized participants) reported relapse data.
elapse was measured either as the number of participants who
elapsed (as identiﬁed by clinical observation or by self-report)
r positive toxicology tests. There was a very low quality body of
vidence of no statistically signiﬁcant difference between acupunc-
ure (as adjunctive or monotherapy) and any comparator up to
ne-month post-intervention (SMD −0.12, 95%CI −0.46 to 0.22,
2 = 67.3%) and at short-term (six-month) follow-up (SMD −0.11,
0.63 to 0.40, I2 = 48.8%; Table 2). Meta-regressions and sub-group
nalyses did not identify any differences by type of substance use
alcohol, stimulants, opioids, or cannabis), acupuncture (auricular
r TCM), co-intervention status (acupuncture as an adjunctive or
s a monotherapy), comparator (passive comparator, TAU, sham
cupuncture, or active comparator), or treatment setting (inpa-
ient or outpatient). There was insufﬁcient evidence to investigate
eographic region (Asian versus non-Asian countries) via meta-
egression, but we found no evidence of publication bias for relapse
Egger’s test: p = 0.23, Begg’s test: p = 0.60).
.4.2. Frequency of substance use. Two RCTs (5%) with 120 partici-
ants (2%) reported data on frequency of substance use, either as
he number of days per week or substance use episodes within
 given time frame. There was a low quality body of evidence
f no statistically signiﬁcant difference between acupuncture (as
djunctive or monotherapy) and any comparator up to one-month
ost-intervention (SMD −0.27, −2.67 to 2.13, I2 = 0%; Table 3).
ne RCT (Bullock et al., 1989) reported a medium clinical effect
n frequency of alcohol use at short-term (six-month) follow-up
SMD −0.79, −1.38 to −0.21) in favor of acupuncture compared to
ham acupuncture (both interventions were adjunctive to pharma-
otherapy and psychosocial intervention). However, the quality of
his body of evidence was very low due to high attrition bias, wide
onﬁdence intervals, and lack of replication of results in another
CT. There was insufﬁcient evidence to investigate publication bias
nd moderators via meta-regression. We did not identify any fur-
her signiﬁcant differences for this outcome in sub-group analyses
y type of substance use, acupuncture, co-intervention status, or
omparator.
.4.3. Quantity of substance use. Three RCTs (7%) with 154 partic-
pants (3%) reported data on quantity of substance use, either as
reathalyzer alcohol level, self-reported amount of substance use
er week, or number of participants consuming at allowable use
evels (e.g., consumption of <60 g of alcohol per day). There was  aependence 163 (2016) 1–15
low quality body of evidence of no signiﬁcant difference up to 0.5-
months post-intervention (SMD 0.01, −0.40 to 0.43, I2 = 0%) and
a very low quality body of evidence of no signiﬁcant difference
at short-term (3.5-month) follow-up (SMD 0.22, −0.34 to 0.79, 1
RCT; Table 4). There was insufﬁcient evidence to investigate pub-
lication bias and moderators via meta-regression for this outcome.
We did not identify any signiﬁcant differences for this outcome
in sub-group analyses by type of substance use, acupuncture, co-
intervention status, or comparator.
3.4.4. Withdrawal/craving symptoms. Twenty RCTs (49%) with
1,175 participants (22%) reported data on withdrawal or craving
symptoms using one of the following measures: the Mainz Alcohol
Withdrawal Scale, the Short Opiate Withdrawal Scale, the Clin-
ical Institute Withdrawal Assessment scale, the Cocaine Craving
Questionnaire-Now scale, the Penn Alcohol Craving Scale, a visual
analog scale, or self-reported symptoms. There was a medium clin-
ical effect in favor of acupuncture (as adjunctive or monotherapy)
versus any comparator up to one-month post-intervention (SMD
−0.57, −0.93 to −0.20, I2 = 79.5%; see Table 5). However, the qual-
ity of this body of evidence is low due to substantial heterogeneity
and a wide conﬁdence interval. Moreover, there was  suggested
evidence of publication bias (Egger’s test: p = 0.003, Begg’s test:
p = 0.04; Fig. 2), trim-and-ﬁll analyses yielded no signiﬁcant differ-
ences (SMD −0.29, −0.66 to 0.09; I2 = 79.5%), and results were no
longer statistically signiﬁcant at short-term (3.5-month) follow-up
(SMD −0.32, −0.91 to 0.28, I2 = 35.4%).
Meta-regressions did not identify any differences by type of
substance use, co-intervention, comparator, treatment setting, and
geographic region. For type of acupuncture, RCTs evaluating TCM
acupuncture had results signiﬁcantly more in favor of the acupunc-
ture intervention group compared to RCTs evaluating auricular
acupuncture (p = 0.006). There was  very low quality evidence of
no statistically signiﬁcant difference between auricular acupunc-
ture and any comparator at post-intervention (SMD −0.29, −0.64
to 0.05, I2 = 69.7%). However, we identiﬁed a large clinical effect
in favor of TCM acupuncture (versus any comparator) at post-
intervention (SMD −1.32, −2.12 to −0.53; I2 = 61.7%), though the
quality of the body of evidence was  very low due to substan-
tial heterogeneity and wide conﬁdence intervals spanning effect
sizes with different clinical conclusions. We also identiﬁed statis-
tically signiﬁcant differences in favor of: acupuncture for opioid
use, acupuncture as an adjunctive therapy, and acupuncture versus
sham acupuncture; however, the quality of the body of evidence
for these analyses was  very low due to reasons such as high risk
of attrition bias, substantial heterogeneity (adjunctive therapy and
sham acupuncture) or inability to judge consistency due to lack
of replication (opioid use), and wide conﬁdence intervals. We  did
not identify any further signiﬁcant differences for this outcome in
sub-group analyses.
3.4.5. Treatment dropout. Twenty-two RCTs (54%) with 2,768 par-
ticipants (53%) reported data on treatment dropout, such as
information on the number of participants receiving or complet-
ing treatment, sessions attended, or days in treatment. There was a
low quality body of evidence of no statistically signiﬁcant difference
(OR 0.82, 0.63 to 1.09, I2 = 10.9%; Table 6). There was no suggested
evidence of publication bias for this overall analysis (Egger’s test:
p = 0.25, Begg’s test: p = 0.34). Meta-regressions did not identify any
differences by type of acupuncture, co-intervention, comparator,
treatment setting, and geographic region. For type of substance use,
the results for alcohol use demonstrated results signiﬁcantly more
in favor of acupuncture compared to the results for stimulant use
(p = 0.023; however, results for alcohol use were not signiﬁcantly
different from results for opioid use (p = 0.436). There was  also a
very low quality body of evidence for a medium effect in favor of
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Table  2
Overall effect and sub-group analyses for relapse.
Subgroupa Number of RCTs Number of participants SMD  (95% CI), random effectsb GRADE quality of body of evidence
All studies
Post-intervention 10 1,175 −0.12 (−0.46 to 0.22) Very lowc,g,i
Short-term follow-up 4 959 −0.11 (−0.63 to 0.40) Very lowc,g,i
Type of substance use (p = 0.266)
Alcohol: post-intervention 2 169 −0.61 (−3.94 to 2.72) Lowc,i
Alcohol: short-term follow-up 2 198 −0.64 (−1.49 to 0.21) Lowc,i
Stimulants: post-intervention 6 1,080 −0.16 (−0.85 to 0.52) Very lowc,g,i
Stimulants: short-term follow-up 1 425 −0.07 (−0.23 to 0.37) Very lowc,h,i
Opioids: post-intervention 2 197 0.21 (−1.85 to 2.27) Lowc,i
Type of acupuncture (p = 0.465)
Auricular: post-intervention 9 1,140 −0.11 (−0.49 to 0.28) Very lowc,g,i
Auricular: short-term follow-up 3 841 −0.01 (−0.50 to 0.47) Lowc,i
TCM: post-intervention 1 35 −0.31 (−1.06 to 0.43) Very lowd,h,i
TCM: short-term follow-up 1 118 −0.57 (−1.36 to 0.22) Very lowc,e,f,h,i
Type of co-intervention status (p = 0.802)
Adjunctive: post-intervention 9 1,025 −0.14 (−0.54 to 0.26) Very lowc,g,i
Adjunctive: short-term follow-up 3 841 See auricular Lowc,i
Monotherapy: post-intervention 1 150 −0.06 (−0.40 to 0.28) Very lowc,e,f,h,i
Monotherapy: short-term follow-up 1 118 −0.57 (−1.36 to 0.22) Very lowc,e,f,h,i
Type of comparator (p = 0.135)
TAU: post-intervention 3 289 0.26 (−0.85 to 1.38) Very lowc,d,g,i
Sham: post-intervention 7 619 −0.07 (−0.36 to 0.22) Lowc,i
Sham: short-term follow-up 2 505 −0.24 (−5.06 to 4.58) Very lowc,g,i
Passive: post-intervention 2 480 −0.24 (−5.44 to 4.96) Very lowc,g,i
Passive: short-term follow-up 1 417 −0.19 (−0.50 to 0.12) Very lowc,h,i
Active: post-intervention 1 40 −0.23 (−0.92 to 0.46) Very lowc,g,i
Active: short-term follow-up 2 454 −0.15 (−3.32 to 3.02) Very lowd,g,i
Reasons for downgrading evidence: cHigh attrition bias, dPerformance bias (participant blinding), eRandom sequence generation, fAllocation concealment, gInconsistent
due  to substantial heterogeneity, hCannot judge consistency (only one RCT), iWide conﬁdence interval spanning effect sizes with different clinical conclusions. *Indicates a
statistically signiﬁcant result.
a Postintervention = 0–2 months follow-up; short-term follow-up = 3–12 months follow-up.
b SMDs < 0 favor acupuncture.
Table 3
Overall effect and sub-group analyses for frequency of substance use.
Subgroupa Number of RCTs Number of participants SMD (95% CI), random effectsb GRADE quality of body of evidence
All studies
Post-intervention 2 120 −0.27 (−2.67 to 2.13) Very lowc,i
Short-term follow-up 1 80 −0.79 (−1.38 to −0.21)c Very lowc,h,i
Type of substance use
Alcohol: post-intervention 1 80 −0.40 (−0.91 to 0.10) Very lowc,g,i
Alcohol: short-term follow-up 1 80 See all studies Very lowc,g,i
Stimulants: post-intervention 1 40 0.00 (−0.72 to 0.72) Very lowc,h,i
Type of acupuncture
Auricular: post-intervention 2 120 See all studies Very lowc,i
Auricular: short-term follow-up 1 80 See all studies Very lowc,g,i
Type of co-intervention status
Adjunctive: post-intervention 2 120 See all studies Very lowc,i
Adjunctive: short-term follow-up 1 80 See all studies Very lowc,g,i
Type of comparator
Sham: post-intervention 2 120 See all studies Very lowc,i
Sham: short-term follow-up 1 80 See all studies Very lowc,g,i
Reasons for downgrading evidence: cHigh attrition bias, dPerformance bias (participant blinding), eRandom sequence generation, fAllocation concealment, gInconsistent due
to  substantial heterogeneity, hCannot judge consistency (only one RCT), iWide conﬁdence interval spanning effect sizes with different clinical conclusions.
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(a Postintervention = 0–2 months follow-up; short-term follow-up = 3–12 months 
b SMDs < 0 favor acupuncture.
c Indicates a statistically signiﬁcant result.
cupuncture for alcohol use (OR 0.34, 0.12 to 0.99, I2 = 71.1%); we
id not identify signiﬁcant differences for stimulant use (OR 1.12,
.86 to 1.45, I2 = 0%) or opioid use (OR 0.58, 95% CI 0.12 to 2.69,
2 = 0%). We  did not identify any further signiﬁcant differences for
his outcome in sub-group analyses.
.4.6. Anxiety symptoms. Six RCTs (15%) with 329 participants
6%) reported data on anxiety symptoms using either the State--up.
Trait Anxiety Inventory, Clinical Anxiety Scale, Self-Rating Anxiety
Scale, or Hamilton Anxiety Scale. There was a low quality body of
evidence of a medium clinical effect in favor of acupuncture at post-
intervention (SMD −0.74, −1.15 to −0.33, I2 = 35.4%), though this
result was no longer statistically signiﬁcant at short-term follow-up
(SMD −1.15, −2.38 to 0.07, I2 = 0%; Table 7). There was  no suggested
evidence of publication bias at post-intervention (Egger’s test:
p = 0.561, Begg’s test: p = 1.000). Meta-regressions did not identify
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Table 4
Overall effect and sub-group analyses for quantity of substance use.
Subgroupa Number of RCTs Number of participants SMD  (95% CI), random effectsb GRADE quality of body of evidence
All studies
Post-intervention 3 154 0.01 (−0.40 to 0.43) Lowc,i
Short-term follow-up 1 72 0.22 (−0.34 to 0.79) Very lowe,f,h,i
Type of substance use
Alcohol: post-intervention 2 114 0.01 (−2.04 to 2.07) Very lowc,e,f,i
Alcohol: short-term follow-up 1 72 See all studies Very lowe,f,h,i
Stimulants: post-intervention 1 40 0.00 (−0.72 to 0.72) Very lowc,e,f,h,i
Type of acupuncture
Auricular: post-intervention 3 154 See all studies Lowc,i
Auricular: short-term follow-up 1 72 See all studies Very lowe,f,h,i
Type of co-intervention status
Adjunctive: post-intervention 3 154 See all studies Lowc,i
Adjunctive: short-term follow-up 1 72 See all studies Very lowe,f,h,i
Type of comparator
TAU: post-intervention 1 42 0.36 (−0.72 to 1.44) Very lowc,d,h,i
Sham: post-intervention 3 155 0.00 (−0.26 to 0.25) Lowc,i
Sham: short-term follow-up 1 72 See all studies Very lowe,f,h,i
Reasons for downgrading evidence: cHigh attrition bias, dPerformance bias (participant blinding), eRandom sequence generation, fAllocation concealment, gInconsistent
due  to substantial heterogeneity, hCannot judge consistency (only one RCT), iWide conﬁdence interval spanning effect sizes with different clinical conclusions. *Indicates a
statistically signiﬁcant result.
a Postintervention = 0–2 months follow-up; short-term follow-up = 3–12 months follow-up.
b SMDs < 0 favor acupuncture.
Table 5
Overall effect and sub-group analyses for withdrawal/craving.
Subgroupa Number of RCTs Number of participants SMD  (95% CI), random effectsb GRADE quality of body of evidence
All studies
Post-intervention 20 1,175 −0.57 (−0.93 to −0.20)c Lowg,i
Short-term follow-up 4 291 −0.32 (−0.91 to 0.28) Very lowc,g,i
Type of substance use (p = 0.372)
Alcohol: post-intervention 8 452 −0.79 (−1.58 to 0.00) Very lowc,g,i
Alcohol: Short-term follow-up 3 195 −0.19 (−1.18 to 0.80) Lowc,i
Stimulants: post-intervention 2 70 −0.47 (−6.87 to 5.93) Very lowg,i
Opioids: post-intervention 9 657 −0.43 (−1.00 to 0.14) Very lowd,g,i
Opioids: short-term follow-up 1 96 −0.58 (−1.05 to −0.12)c Very lowd,h,i
Type of acupuncture (p = 0.006)
Auricular: post-intervention 15 837 −0.29 (−0.64 to 0.05) Very lowc,g,i
Auricular: short-term follow-up 4 291 See all studies Very lowc,g,i
TCM: post-intervention 5 338 −1.32 (−2.12 to −0.53)c Very lowd,g,i
Type of co-intervention status (p = 0.120)
Adjunctive: post-intervention 15 915 −0.43 (−0.79 to −0.06)c Very lowc,g,i
Adjunctive: short-term follow-up 4 291 See all studies Very lowc,g,i
Monotherapy: post-intervention 5 260 −1.17 (−2.50 to 0.16) Lowg,i
Type of comparator (p = 0.392)
TAU: Post-intervention 4 249 −0.81 (−2.33 to 0.71) Very lowc,d,g,i
TAU: short-term follow-up 1 42 −0.33 (−1.47 to 0.81) Very lowc,h,i
Sham: post-intervention 12 592 −0.32 (−0.79 to 0.15) Very lowc,g,i
Sham: short-term follow-up 3 195 −0.79 (−1.38 to −0.21)c Very lowc,h,i
Passive: [ost-intervention 3 183 −1.00 (−2.16 to 0.16) Very lowc,g,i
Active: post-intervention 3 246 −1.16 (−3.74 to 1.43) Very lowc,g,i
Active: short-term follow-up 1 96 See opioids Very lowd,h,i
Reasons for downgrading evidence: cHigh attrition bias, dPerformance bias (participant blinding), eRandom sequence generation,f Allocation concealment,g Inconsistent due
to  substantial heterogeneity, hCannot judge consistency (only one RCT), iWide conﬁdence interval spanning effect sizes with different clinical conclusions.
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ny differences by type of substance use, co-intervention, compara-
or, and geographic region; we did identify a low quality body of
vidence for a large clinical effect of acupuncture targeting opioid
se (SMD −0.80, −1.30 to −0.29, I2 = 29.1%) and a medium clinical
ffect of acupuncture as an adjunctive therapy (SMD −0.78, −1.42
o −0.15, I2 = 32%). There was insufﬁcient evidence to investigate
ype of acupuncture and treatment setting via meta-regression, as
ell as publication bias, for this outcome, though we  did identify a
ery low quality body of evidence for a large clinical effect in favor-up.
of auricular acupuncture with electro-stimulation (as an adjunct
to psychosocial intervention TAU) versus TAU alone (SMD −1.40,
−2.71 to −0.08, 1 RCT). We  did not identify any further signiﬁcant
differences in sub-group analyses.3.4.7. Health-related quality of life. Three RCTs (7%) with 254 par-
ticipants (5%) reported data on health-related quality of life using
either the SF-36 General Health or an adapted version of the World
Health Organization Quality of Life scale. There was a low quality
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Table  6
Overall effect and sub-group analyses for treatment dropout.
Subgroupa Number of RCTs Number of participants OR (95% CI), random effectsb GRADE quality of body of evidence
All studies
Post-intervention 22 2,768 0.82 (0.63 to 1.09) Lowc,i
Type of substance use (p = 0.023)
Alcohol: post-intervention 8 764 0.34 (0.12 to 0.99)c Very lowc,d,g,i
Stimulants: post-intervention 6 795 1.12 (0.86 to 1.45) Lowc,i
Opioids: post-intervention 3 171 0.58 (0.12 to 2.69) Lowd,i
Type of acupuncture (p = 0.199)
Auricular: post-intervention 18 2,414 0.88 (0.69 to 1.12) Lowc,i
TCM: post-intervention 4 264 0.29 (0.05 to 1.51) Lowd,i
Type of co-intervention status (p = 0.281)
Adjunctive: post-intervention 18 2,315 0.86 (0.68 to 1.08) Lowd,i
Monotherapy: post-intervention 4 363 0.42 (0.04 to 4.37) Very lowc,g,i
Type of comparator (p = 0.313)
TAU: post-intervention 7 973 1.25 (0.57 to 2.32) Very lowd,g,i
Sham: post-intervention 11 1,336 0.74 (0.41 to 1.34) Very lowc,g,i
Passive: post-intervention 5 630 1.46 (0.54 to 3.99) Lowg,i
Active: post-intervention 8 1,136 0.71 (0.38 to 1.33) Very lowc,g,i
Reasons for downgrading evidence: cHigh attrition bias, dPerformance bias (participant blinding), eRandom sequence generation, fAllocation concealment, g Inconsistent
due  to substantial heterogeneity, hCannot judge consistency (only one RCT), iWide conﬁdence interval spanning effect sizes with different clinical conclusions.
a Postintervention = 0–2 months follow-up; short-term follow-up = 3–12 months follow-up.
b ORs < 0 favor acupuncture.
c Indicates a statistically signiﬁcant result.
Table 7
Overall effect and sub-group analyses for anxiety symptoms.
Subgroupa Number of RCTs Number of participants SMD  (95% CI), random effectsb GRADE quality of body of evidence
All studies
Post-intervention 6 329 −0.74 (−1.15 to −0.33)c Lowc,i
Short-term follow-up 1 42 −1.15 (−2.38 to 0.07) Very lowc,h,i
Type of substance use (p = 0.622)
Alcohol: post-intervention 2 76 −0.67 (−8.00 to 6.67) Very lowc,g,i
Opioids: post-intervention 4 253 −0.80 (−1.30 to −0.29)c Lowc,i
Type of acupuncture
Auricular: post-intervention 1 42 −1.40 (−2.71 to −0.08)c Very lowc,h,i
TCM: post-intervention 3 212 −0.73 (−1.53 to 0.06) Lowc,i
Type of co-intervention status (p = 0.783)
Adjunctive: post-intervention 4 226 −0.78 (−1.42 to −0.15)c Lowc,i
Monotherapy: post-intervention 2 103 −0.69 (−5.27 to 3.88) Very lowc,g,i
Type of comparator (p = 0.138)
TAU: post-intervention 2 102 −0.88 (−3.50 to 1.74) Lowc,i
Sham: post-intervention 2 77 −0.09 (−2.06 to 1.88) Lowc,i
Passive: post-intervention 3 193 −0.80 (−1.76 to 0.17) Very lowc,g,i
Reasons for downgrading evidence: cHigh attrition bias, dPerformance bias (participant blinding), eRandom sequence generation, fAllocation concealment, g Inconsistent due
to  substantial heterogeneity, hCannot judge consistency (only one RCT), iWide conﬁdence interval spanning effect sizes with different clinical conclusions.
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ody of evidence of no statistically signiﬁcant difference at post-
ntervention (SMD −0.15, −0.45 to 0.15, I2 = 0%; Table 8). There was
nsufﬁcient evidence to investigate publication bias and modera-
ors via meta-regression for this outcome. We did not identify any
igniﬁcant differences for this outcome in sub-group analyses.
.5. Safety of acupuncture for SUDs
We  identiﬁed 12 RCTs (29%) with 1,221 participants (23%) pro-
iding data on adverse events (Table 9). Only one study reported
roactively asking participants about potential side effects, while
thers passively captured information. Of the safety data reported,
e did not ﬁnd strong evidence indicating that acupuncture is asso-
iated with any serious adverse event. Mild adverse events included
ocal side effects, convulsions, delirium tremens, slight bleeding at
he site of acupuncture, treatment withdrawal due to aversion to or-up.
actual needle pain, or “adverse events” generally. A small propor-
tion experienced mild adverse events, either due to acupuncture
itself (e.g., bleeding at site of insertion), possibly co-interventions
(e.g., pharmacotherapy), or the detoxiﬁcation process.
4. Discussion
Including 41 RCTs conducted over multiple decades, this review
is the most comprehensive on acupuncture for SUDs in scope: we
report results for multiple outcomes targeted by this intervention
and used broad inclusion criteria facilitated by several pre-speciﬁed
subgroup analyses. The results of this review do not support the
use of acupuncture for substance use outcomes; we  did not ﬁnd
consistent evidence in support of acupuncture for relapse and
quantity of substance use, and the one result we found in favor
of frequency of substance use was based on only one small trial.
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Table 8
Overall effect and sub-group analyses for health-related quality of life.
Subgroupa Number of RCTs Number of Participants SMD  (95% CI), random effectsb GRADE Quality ofBody of Evidence
All studies
Post-intervention 3 254 −0.15 (−0.45 to 0.15) Lowc,i
Type of substance use
Stimulants: post-intervention 1 157 −0.13 (−0.45 to 0.18) Very lowc,h,i
Opioids: post-intervention 2 157 −0.17 (−1.98 to 1.64) Lowc,i
Type of co-intervention status
Adjunctive: post-intervention 3 314 See all studies Lowc,i
Type of comparator
TAU: Post-intervention 2 254 −0.10 (−0.66 to 0.45) Lowc,i
Sham: post-intervention 2 218 −0.19 (−1.23 to 0.85) Lowc,i
Reasons for downgrading evidence: cHigh attrition bias, dPerformance bias (participant blinding), eRandom sequence generation, fAllocation concealment, gInconsistent
due  to substantial heterogeneity, hCannot judge consistency (only one RCT), iWide conﬁdence interval spanning effect sizes with different clinical conclusions. *Indicates a
statistically signiﬁcant result.
a Postintervention = 0–2 months follow-up; short-term follow-up = 3–12 months follow-up.
b SMDs < 0 favor acupuncture.
Table 9
Adverse events in included studies.
Study Reported adverse events
Avants et al. (2000) One participant receiving auricular acupuncture along with pharmacotherapy withdrew from the study due to
hospitalization, while another in the sham acupuncture arm passed away
Bullock et al. (2002) Three-arm trial, with all arms receiving some form of acupuncture in combination with a psychosocial intervention (TAU):
two participants in the auricular acupuncture arm, ﬁve in the sham acupuncture arm, and one in a symptom-based
acupuncture arm withdrew from due to aversion to needle pain
Chan et al. (2014) Two participants receiving auricular acupuncture (with electro-stimulation) and one participant receiving sham acupuncture
(superﬁcial needle insertion) reported slight bleeding at the site of acupuncture, with an additional participant experiencing
mild hand numbness when receiving acupuncture at acupoints on the hand
Chang et al. (2010) No adverse events during or after the study period
Kunz et al. (2007) Six participants receiving acupuncture and drug therapy reported negative side effects such as pain and mild bleeding,
whereas ﬁve participants receiving aroma therapy and pharmacotherapy reported negative side effects such as agitation,
sneezing, negative thoughts, or sore throat
Lee et al. (2014) No participants reported deﬁnite complaints or side effects caused by acupuncture treatment
Lua and Talib (2013) Proactively asked participants about potential side effects. 38–66% of participants receiving auricular acupuncture as an
adjunct to drug therapy reported dizziness, tingling sensations, nausea, slight fever, light headache, pain, dry mouth, slight
bleeding, and drowsiness
Otto et al. (1998) Pain from or fear of needles
Rampes et al. (1997) Withdrawal from the study due to pain from treatment by a participant in a group receiving sham acupuncture as an adjunct
to  a psychosocial intervention. Slight bleeding at the site of needle insertion nausea or dizziness. Reported general side effects
without speciﬁcally indicating how many participants in the different treatment groups experienced them
Trumpler et al. (2003) No local side effects or development of delirium tremens by any study participant; however, one participant receiving
auricular acupuncture as an adjunct to drug therapy experience self-limiting generalized convulsions of ﬁve minutes in
duration on the ﬁfth day of withdrawal while she was sleeping, though this was judged to be a withdrawal-related epileptic
peciﬁc
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Washburn et al. (1993) Reported general side effects without s
experienced them
e  did identify consistent differences in favor of acupuncture for
ithdrawal/craving and anxiety symptoms. The body of evidence
nderlying these analyses, however, is of low to very low quality
ue to attrition bias, high heterogeneity, and/or wide conﬁdence
ntervals, and the overall analysis for withdrawal/craving has sug-
ested evidence for publication bias. Moreover, consistent effects
ere not found for health-related quality of life and treatment
ropout. Results suggest that acupuncture is not typically associ-
ted with serious adverse events, though some participants may
xperience slight bleeding or slight pain at the needle insertion
ite. However, the available safety data is limited, as 29 RCTs (71%)
id not report any information on adverse events.
We  found no robust evidence to suggest that results dif-
ered systematically by acupuncture as an adjunctive therapy or
onotherapy, or by type of comparator. However, we did ﬁnd
igniﬁcant differences in favor of acupuncture as an adjunctive
herapy for the two outcomes with the most consistent positive
ffects (i.e., withdrawal/craving and anxiety symptoms). Meta-
egressions did suggest that some results differ by the type of
ubstance targeted (treatment dropout results were statisticallyally indicating how many participants in the different treatment groups
signiﬁcant for alcohol use) and by acupuncture type (TCM acupunc-
ture, compared to auricular acupuncture, had effects signiﬁcantly
more in favor of the acupuncture intervention group for with-
drawal/craving symptoms and treatment dropout).
The above results are signiﬁcantly limited by two  factors. First,
several outcomes—frequency and of use, anxiety symptoms, and
health-related quality of life—had less than 10 studies for their
overall analyses, with far less in sub-group analyses per outcome.
Consequently, there was insufﬁcient evidence for meta-regressions
for these outcomes, and sub-group analyses were often down-
graded due to wide conﬁdence intervals that are characteristic
of small evidence bases. We  therefore caution any strong conclu-
sions that results do not differ by our pre-speciﬁed moderators
for these outcomes. Moreover, the large residual heterogeneity
for many analyses—particularly relapse and withdrawal/craving
symptoms—indicates that there are likely other important sources
of clinical heterogeneity not pre-speciﬁed in our protocol and ana-
lyzed in our review. Of note, acupuncture interventions varied
by dosage, acupoints, and co-intervention content, all of which
provide sources of clinical heterogeneity. We have provided all
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xtracted data on included studies to facilitate further analyses of
his evidence base by interested readers (Online Supplements 4–6).
astly, long-term effects are uncertain, as most outcome data were
rom post-intervention or shortly thereafter, only eight RCTs pro-
ided data after two months, and this body of evidence is at high
isk of attrition bias—likely because treatments often targeted a
ard-to-reach population.
.1. Other reviews in this area
The results of this review are comparable to previous meta-
nalyses evaluating acupuncture for alcohol dependence (Cho and
hang, 2009) and cocaine dependence (Gates et al., 2006; Mills
t al., 2005), which concluded that there were equivocal results
etween acupuncture and comparator interventions for substance
se outcomes and treatment dropout. Moreover, like the current
eview, these reviews indicated that most included studies were
ampered by poor methodological quality and loss-to-follow-up,
eakening the conclusions that can be drawn from this body of
vidence.
Another review on acupuncture (with opioid receptor agonists)
ound a clinically large and statistically signiﬁcant effect in favor of
cupuncture as an adjunctive therapy for withdrawal symptoms
Liu et al., 2009). The current review also indicates statistically
igniﬁcant effects in favor of acupuncture for withdrawal/craving
ymptoms at post-intervention generally, short-term follow-up
or opiate use speciﬁcally, post-intervention for TCM acupuncture,
ost-intervention for adjunctive therapy, and short-term follow-up
gainst active comparators. However, our conclusions differ from
he other review in various ways: we generally found medium
ffects, whereas the other review found large effects; we  con-
ucted a formal assessment of the quality of the body of evidence,
hich lessened our conﬁdence in the effect estimates found; the
ther review included mostly Chinese-language studies that were
xcluded from this review; and the other review reported pos-
tive effects only at days 1, 7, 9, and 10 of treatment, with no
ositive effects at other days of treatment or at any points post-
ntervention, while our review focused on post-intervention and
hort-term follow-up.
.2. Strengths and limitations
This review has several strengths: an a priori research design,
uplicate study selection and data extraction of study information,
omprehensive search of electronic databases, inclusion of grey
iterature (dissertations or graduate theses), and risk of bias assess-
ents and comprehensive quality of evidence assessments used
o formulate review conclusions. However, some limitations are
orth noting. First, we only focused on needle acupuncture; related
nterventions (e.g., acupressure) may  yield different effects. Sec-
ndly, we did not contact trial authors for missing data or to identify
ther potential studies not identiﬁed by the search strategy; while
e searched several databases speciﬁc to CAM (AMED, MANTIS),
ther databases to which we did not have access (e.g., Acubriefs,
cudoc2 RCT) may  include acupuncture studies not in major medi-
al databases such as PubMed (Cogo et al., 2011). In addition, some
eta-analyses in this review only pool results from two RCTs or
rovide data from only one RCT that has not been replicated, and
igniﬁcant heterogeneity existed for several outcomes. We  also did
ot consider response expectancies (i.e., participant expectations
hat acupuncture will have positive effects) in our analyses, though
his information was not reported in this body of evidence.ependence 163 (2016) 1–15 13
4.3. Implications for future research and practice
Similar to previous reviews, the generally poor methodologi-
cal quality of the body of evidence, as well as limited available
evidence for speciﬁc outcomes, prevents strong conclusions about
acupuncture for SUDs. More well-designed, rigorous, and large
RCTs would facilitate an evidence base that can more deci-
sively provide estimates of acupuncture for SUDs. For future
researchers interested in further developing this evidence base,
we provide several concrete suggestions based on the current
evidence we  identiﬁed. Firstly, given evidence of potential publica-
tion bias for withdrawal/craving, researchers should pre-register
their trials and report all results regardless of their statistical
signiﬁcance (Dickersin and Renne, 2003). Secondly, as resources
allow, researchers should aim to measure all outcomes tar-
geted by acupuncture when used to treat SUDs. The number
of RCTs contributing data to frequency and quantity of use,
withdrawal/craving, and anxiety symptoms are particularly low,
though even the most-measured outcome (treatment dropout) was
reported in only half of identiﬁed studies. Researchers should also
seek to measure outcomes at long-term follow-ups, as less than
20% of RCTs provided data on any outcome after two  months, while
no RCTs provided data up to one-year post-intervention. Further-
more, when using self-report measures, researchers should employ
psychometrically-validated measures for adult populations with
SUDs, rather than bespoke Likert scales. Lastly, if investigated
in future RCTs, acupuncture should likely be adjunctive to an
evidence-based intervention for the SUD population and setting
under investigation, as the positive results we identiﬁed for with-
drawal/craving and anxiety symptoms held in sub-group analyses
for acupuncture as an adjunctive therapy, and numerous evidence-
based pharmacological and psychosocial interventions for SUDs
have been identiﬁed (Columbia, 2012). Delivery of acupuncture
as a mono-therapy may  consequently violate the ethical princi-
ple of equipoise. To facilitate the use of future RCTs, we implore
researchers investigating acupuncture to report their studies in full
compliance with the STRICTA recommendations for acupuncture
trials (MacPherson et al., 2002).
Policy-makers, funders, and practitioners may also wish to con-
vene in order to decide the priorities (if any) for future research,
practice, and policy of acupuncture for SUDs. For instance, an evi-
dence base of over 40 RCTs and growing popularity in current
practice likely merits acupuncture as an intervention to appraise in
updates to clinical practice guidelines for SUDs (APA, 2006; CAMH,
2011; NICE, 2011; VA/DoD, 2009; WHO, 2014). While there was  evi-
dence in favor of acupuncture for withdrawal/craving and anxiety
symptoms, those considering the use of acupuncture for these out-
comes should note that the body of evidence for these results is of
low to very low quality. The limited available evidence on adverse
events suggests that acupuncture is not typically associated with
serious adverse events, though some participants may  experience
slight bleeding or slight pain at the needle insertion site. Given
the quality of evidence, there is uncertainty with regards to the
magnitude or stability of effect estimates.
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